[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), reported multiple equity transactions on 09/15/2025 executed pursuant to a Rule 10b5-1 trading plan adopted March 4, 2025. The Form 4 shows option exercises and RSU vesting events, plus a sale and shares withheld for taxes. Reported activity includes option exercises at exercise prices of $11.53, $6.82 and $5.01, a sale of 4,150 Class A shares at $56 each, and withholding of 39,872 shares to cover tax obligations. The final line reports 310,888 shares of Class A common stock beneficially owned following the transactions. The Form 4 was signed by an attorney-in-fact on 09/17/2025.

Positive

• Transactions executed under a Rule 10b5-1 plan, indicating adherence to a pre-established trading policy
• Post-transaction beneficial ownership disclosed as 310,888 Class A shares, providing transparency

Negative

• Insider sale of 4,150 shares at $56 was reported, showing some disposition of holdings
• 39,872 shares withheld for taxes reduced net new shares received from RSU settlements

Insights

Securities Analyst

TL;DR: Insider exercised options and recorded a small open-market sale under a 10b5-1 plan; final beneficial ownership reported at 310,888 shares.

The filing documents option exercises at three exercise prices and multiple RSU vesting events occurring on September 15, 2025, with a reported sale of 4,150 Class A shares at $56 and withholding of 39,872 shares for taxes. Transactions are explicitly stated to have been effected under a Rule 10b5-1 plan adopted March 4, 2025, which indicates preplanned execution rather than ad-hoc trading. The Form 4 gives a clear post-transaction beneficial ownership figure of 310,888 Class A shares, enabling investors to update insider ownership models.

Corporate Governance Expert

TL;DR: Use of a documented 10b5-1 plan and attorney-in-fact signature demonstrates procedural compliance with insider trading rules.

The report notes that the exercises and sale were effected pursuant to a Rule 10b5-1 plan adopted March 4, 2025 and the Form 4 is signed by an attorney-in-fact. These details support that the transactions followed a pre-established plan and required authorization. The filing discloses withholding of shares for tax obligations related to RSU settlement, a routine administrative outcome of equity compensation vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/15/2025		M(1)		250	A	$11.53	278,904	D
Class A Common Stock	09/15/2025		M(1)		1,800	A	$6.82	280,704	D
Class A Common Stock	09/15/2025		M(1)		2,100	A	$5.01	282,804	D
Class A Common Stock	09/15/2025		S(1)		4,150	D	$56	278,654	D
Class A Common Stock	09/15/2025		M		72,106	A	(2)	350,760	D
Class A Common Stock	09/15/2025		F		39,872(2)	D	$53.96	310,888	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.53	09/15/2025		M(1)			250	(3)	03/01/2033	Class A Common Stock	250	$0	47,356	D
Stock Option (right to buy)	$6.82	09/15/2025		M(1)			1,800	(4)	08/10/2032	Class A Common Stock	1,800	$0	116,262	D
Stock Option (right to buy)	$5.01	09/15/2025		M(1)			2,100	(5)	02/24/2032	Class A Common Stock	2,100	$0	176,142	D
Restricted Stock Unit	(6)	09/15/2025		M			9,356	(7)	(7)	Class A Common Stock	9,356	$0	18,713	D
Restricted Stock Unit	(6)	09/15/2025		M			16,495	(8)	(8)	Class A Common Stock	16,495	$0	65,983	D
Restricted Stock Unit	(6)	09/15/2025		M			16,297	(9)	(9)	Class A Common Stock	16,297	$0	97,784	D
Restricted Stock Unit	(6)	09/15/2025		M			19,359	(10)	(10)	Class A Common Stock	19,359	$0	193,584	D
Restricted Stock Unit	(6)	09/15/2025		M			10,599	(11)	(11)	Class A Common Stock	10,599	$0	148,389	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

3. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

5. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.

6. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

8. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2022.

9. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

10. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

11. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed this Form 4 for HIMS and what is their role?

The filing reports Michael Chi, Chief Commercial Officer, as the reporting person.

Were the transactions executed under a 10b5-1 plan?

Yes. The Form 4 states the stock option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2025.

What specific transactions were reported on 09/15/2025?

The report lists option exercises at $11.53, $6.82, and $5.01, a sale of 4,150 shares at $56, RSU vesting, and 39,872 shares withheld for taxes.

How many Class A shares does Michael Chi beneficially own after these transactions?

The Form 4 reports 310,888 shares of Class A common stock beneficially owned following the reported transactions.

When was the Form 4 signed?

The Form 4 is signed by Kimberly Mather, Attorney-in-Fact for Michael Chi, dated 09/17/2025.